Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (101-110 of 303) with videos related to

Pageof 31
Sort By:
Cancer Chemotherapy and Pharmacology|November 26, 2010
Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsJong-Mu Sun, Mi Hyun Nam, Jae Yong Chung, et al.
Investigational New Drugs|July 2, 2011
Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinomaHee Kyung Ahn, Soohyeon Lee, Jong-Mu Sun, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2021
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancerHan Gyul Yoon, Dongryul Oh, Jae Myoung Noh, et al.
Oncotarget|February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaBo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.
Cancer Research and Treatment|May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung CancerJiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinomaJiyun Lee, Hyun Ae Jung, Youjin Kim, et al.
Biomaterials|October 30, 2015
Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cellsChang Eun Yoo, Hui-Sung Moon, Yeon Jeong Kim, et al.
Japanese Journal of Clinical Oncology|February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practiceJiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.
European Journal of Immunology|January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancerBo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.
Translational Cancer Research|July 11, 2024
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancerYe Ji Jung, Joonghyun Ahn, Sehhoon Park, et al.
Pageof 31

Showing results (101-110 of 303) with videos related to

Sort By:
Pageof 31
Cancer Chemotherapy and Pharmacology|November 26, 2010
Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsJong-Mu Sun, Mi Hyun Nam, Jae Yong Chung, et al.
Investigational New Drugs|July 2, 2011
Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinomaHee Kyung Ahn, Soohyeon Lee, Jong-Mu Sun, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2021
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancerHan Gyul Yoon, Dongryul Oh, Jae Myoung Noh, et al.
Oncotarget|February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaBo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.
Cancer Research and Treatment|May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung CancerJiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinomaJiyun Lee, Hyun Ae Jung, Youjin Kim, et al.
Biomaterials|October 30, 2015
Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cellsChang Eun Yoo, Hui-Sung Moon, Yeon Jeong Kim, et al.
Japanese Journal of Clinical Oncology|February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practiceJiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.
European Journal of Immunology|January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancerBo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.
Translational Cancer Research|July 11, 2024
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancerYe Ji Jung, Joonghyun Ahn, Sehhoon Park, et al.
Pageof 31